Healthcare stocks provide defensive growth. The sector includes pharmaceutical firms, biotech innovators, hospitals, and medical device companies.
Pharmaceutical stocks include Pfizer, Johnson & Johnson, and Merck in the U.S.. Their prices rise with blockbuster drug sales. For example, Roche benefits from oncology drugs.
Biotech stocks cover CRISPR Therapeutics and Vertex. Their prices rise on scientific breakthroughs. For instance, Gilead gained from antiviral treatments.
Hospital and healthcare service stocks include HCA Healthcare, UnitedHealth, and Anthem. Their prices reflect healthcare demand.
Healthcare ETFs such as XLV, buy embecta shares iShares Global Healthcare, and ARK Genomic Revolution bundle leaders across pharma, biotech, and services.
The healthcare sector remains resilient in recessions. Investors mix Johnson & Johnson, Novartis, and Daiichi Sankyo with Biogen and BeiGene to gain wide exposure.
In conclusion, healthcare stocks offer long-term opportunity. Their stock prices reward strategic investors.